United-Guardian, Inc. (NASDAQ:UG – Get Free Report) passed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $7.19 and traded as low as $7.05. United-Guardian shares last traded at $7.10, with a volume of 8,154 shares.
Analysts Set New Price Targets
Separately, Weiss Ratings raised United-Guardian from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.
Check Out Our Latest Stock Report on United-Guardian
United-Guardian Stock Down 0.3%
United-Guardian (NASDAQ:UG – Get Free Report) last announced its quarterly earnings data on Friday, August 7th. The company reported $0.16 EPS for the quarter. The business had revenue of $3.11 million for the quarter. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%.
United-Guardian Dividend Announcement
The business also recently declared a dividend, which was paid on Tuesday, August 4th. Investors of record on Tuesday, July 28th were issued a $0.30 dividend. This represents a dividend yield of 819.0%. The ex-dividend date of this dividend was Tuesday, July 28th. United-Guardian’s payout ratio is 111.11%.
Hedge Funds Weigh In On United-Guardian
Several institutional investors and hedge funds have recently bought and sold shares of UG. BlackRock Inc. purchased a new stake in United-Guardian in the second quarter worth $105,000. United Capital Financial Advisors LLC purchased a new position in shares of United-Guardian during the 2nd quarter valued at $143,000. Finally, Gamco Investors INC. ET AL grew its stake in shares of United-Guardian by 1.2% during the 1st quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after acquiring an additional 1,888 shares during the period. 23.16% of the stock is owned by institutional investors.
United-Guardian Company Profile
United-Guardian, Inc develops, manufactures, and markets specialty products for the personal care, pharmaceutical, medical, and industrial markets. The company’s products are used by manufacturers in formulations including cosmetics, skin-care products, pharmaceuticals, and medical treatments.
United-Guardian’s product portfolio includes Lubrajel, a water-soluble lubricating and moisturizing agent used in personal-care and pharmaceutical applications, as well as Renacidin, a medical solution used for the dissolution and prevention of certain urinary tract calculi and encrustations.
Further Reading
- Five stocks we like better than United-Guardian
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.
